PCM
ASTX

Prelude Capital Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Prelude Capital Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,183
Closed -$44K – 2240
2013
Q3 		$44K Sell
5,183
-23,235
-82% -$147K 0.01% 947
2013
Q2 		$117K Buy
+28,418
New +$153K 0.03% 600

Prelude Capital Management's ASTX Position: Q4 2013 in Review

Prelude Capital Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 5,183 shares — an estimated $44K sold.

Prelude Capital Management first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $117K in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Prelude Capital Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Prelude Capital Management sold 5,183 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $44K.
  • Prelude Capital Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Prelude Capital Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $117K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Prelude Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.